Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Hyaluronan Fragment by Nakhia Impex for Cancer Pain: Likelihood of Approval
Hyaluronan Fragment is under clinical development by Nakhia Impex and currently in Phase II for Cancer Pain. According to GlobalData,...
Data Insights
Hyaluronan Fragment by Nakhia Impex for Chronic Skin Inflammation: Likelihood of Approval
Hyaluronan Fragment is under clinical development by Nakhia Impex and currently in Phase II for Chronic Skin Inflammation. According to...